Remel Xpect Clostridium difficile Toxin A/B, IVD, 40 clostridium difficile toxin A/B tests, REF 24640. Product Usage: The test kit is a rapid in vitro immunochromatographic test for the direct, qualitative detection of Clostridium difficile Toxin A and/or B in human fecal specimens. The test is intended for use as an aid in diagnosis of Clostridium difficile-associated disease.
Published February 20, 2013 · Recall initiated: August 20, 2012
Summary
FDA records medical device Class II recall Z-0807-2013, published February 20, 2013 and initiated August 20, 2012. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 50 units; Lot: Lot 141764. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The firm is recalling the products due to a potential for false negative test results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Remel Inc
- Distributor
- Worldwide Distribution - USA Nationwide and the countries Canada and the United Kingdom
- Lot
- Lot 141764
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThermo SCIENTIFIC, Sensititre STP6F, Gram Negative IVD ASTDecember 14, 2022
- FDAThio Med w/Dex, Hem, Vit K (5ml) 100/PK Product Usage; Recommended for use in qualitative procedures as aMay 29, 2019
- FDAThio Med w/Dex, Hemin, Vit K (5ml) 20/PK Product Usage: Recommended for use in qualitative procedures as aMay 29, 2019
- FDABlood Agar (TSA w/ 5% Sheep Blood) Plate, For In Vitro Diagnostic Use, Remel, Lenexa, KS 66215 Product Usage:May 3, 2017
- FDARemel Xpect Clostridium difficile Toxin A/B, IVD, 20 clostridium difficile toxin A/B tests, REF 24650. ProductFebruary 20, 2013
- FDAOxoid Antimicrobial Susceptibility Discs, Cefoxitin 30ug REF CT0119B, packaged with 50 discs per cartridge, 5February 20, 2013
Questions about this recall
Was Remel Xpect Clostridium difficile Toxin A/B, IVD, 40 clostridium difficile toxin A/B tests, REF 24640. Product Usage: The test kit is a rapid in vitro immunochromatographic test for the direct, qualitative detection of Clostridium difficile Toxin A and/or B in human fecal specimens. The test is intended for use as an aid in diagnosis of Clostridium difficile-associated disease. recalled?
Yes. FDA published recall Z-0807-2013 on February 20, 2013. Reported hazard: The firm is recalling the products due to a potential for false negative test results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter